Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PSAPL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PART1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
OR2B2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
S100A8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC100129603 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LINC00488 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
LOC100132005 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors
ZMYM2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OSMR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC101928269 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARHGEF28 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PSG7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CPM - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PIAS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARAP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on